Skip to main content
Signal8

PMGC Holdings Inc. (ELAB)

PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

PMGC Holdings Inc. logo

PMGC Holdings Inc.

NASDAQ:ELABHealthcare
AH+1.35%$1.50
Close$1.48-10.84%
Mkt Cap$1.73M
EV-$1.03M
Float1.17M
O/S1.17M
VOL159K sh
$ Vol$248K
RVOL0.22×
Inst Own1.7%
SI1.6%
Net Cash/Sh+$2.36
Dilution
PMGC Holdings Inc. logoNASDAQ:ELABAH$1.50+1.35%
Financials Summary
Revenue$590K
Net Income-$7.71M
Total Assets$12.87M
Free Cash Flow-$6.38M
Debt & Equity
Debt 25%
Equity 75%
Preferred 0%
Total Debt$2.64M
Total Equity$7.84M
Preferred Stock$637
Shares Outstanding
Short Interest

No short interest data available.

Split History7 splits · 6 reverse
2-year cumulative
1:1,176,000Over cap

Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period

  1. 1:10Reverse split
    Aug 21, 202610 shares → 1
  2. 1:6Reverse split
    Mar 10, 20266 shares → 1
  3. 1:4Reverse split
    Jan 6, 20264 shares → 1
  4. 1:3.5Reverse split
    Sep 2, 20253.5 shares → 1
  5. 1:7Reverse split
    Mar 10, 20257 shares → 1
  6. 1:200Reverse split
    Nov 27, 2024200 shares → 1
  7. 2:1Forward split
    Jun 2, 20041 share → 2
Balance Sheet Details
Assets$12.87M
Liabilities$5.03M
Accounts Receivable$341K
Accounts Payable$698K
Inventory$95K
PP&E (Net)$2.13M
Goodwill$978K
Intangible Assets$2.89M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Revenue$590K$2.47M$0$766K$827$0
YoY Growth-76.1%--92557.4%--
Cost of Revenue$515K$670K$554$319K$88$0
Gross Profit$75K$1.8M-$554$447K$739$0
Gross Margin12.7%72.8%-58.4%89.4%-
Research and Development$147K$105K$7K$229K$124K$119K
Selling, General, and Administrative$1.62M$856K$1.13M$1.73M$634K$103K
Other$5.68M$2.7M$0$277K$28K$0
Total Operating Expenses$7.45M$3.66M$1.14M$2.24M$786K$222K
Operating Income (EBIT)-$7.38M-$1.87M-$1.14M-$1.79M-$785K-$222K
Operating Margin-1250.1%-75.7%--233.4%-94928.9%-
Interest Expense$547K$735K$0$3K$0$0
Interest Income$118K$13K$6K$8K$0$0
Other Income (Expense)-$373K-$2.15M-$516K-$12K$323-$1K
Income Before Tax (EBT)-$7.75M-$4.02M-$1.66M-$1.8M-$785K-$223K
Income Tax Expense$31K$0$0$0$0$0
Net Income-$7.71M-$6.25M-$4.3M-$1.8M-$785K-$223K
Net Income Margin-1306.3%-253.1%--234.9%-94889.8%-
Supplementary Data
EPS-3787.40-65923.20-477946.33-158.40-887.71-19.79
Diluted EPS-3787.40-65923.20-1511.43-158.40-887.71-19.79
Weighted Average OS2,03595911,34488411,263
EBITDA-$7.27M-$3.27M-$1.13M-$1.79M-$782K$0
EBITDA Margin-1231.4%-132.5%--233.7%-94556.5%-
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Assets
Current Assets
Cash and Cash Equivalents$5.4M$3.98M$3.33M$1.15M$412K$13K
Short-Term Investments$0$0$0$0$0$0
Cash and Short-Term Investments$5.4M$3.98M$3.33M$1.15M$412K$13K
Accounts Receivable$341K$5K$36K$13K$2K$371
Inventory$95K$1K$496K$230K$161K$0
Other Current Assets$1.03M$1.19M$0$0$0$0
Total Current Assets$6.87M$6.05M$4.92M$1.55M$637K$17K
Long-Term Assets
Property, Plant & Equipment Net$2.13M$1K$2K$330K$30K$0
Goodwill$978K$0$0$0$0$0
Intangible Assets$2.89M$2.8M$0$0$0$0
Long-Term Investments$0$139K$0$11K$0$0
Deferred Tax Assets$0$0$0$0$0$0
Other Long-Term Assets$0$0$269K$0$0$0
Total Long-Term Assets$6M$2.94M$270K$341K$30K$0
Other Assets$0$0$1$0$0$0
Total Assets$12.87M$8.99M$5.19M$1.89M$666K$17K
Liabilities
Current Liabilities
Accounts Payable$698K$481K$596K$211K$98K$154
Short-Term Debt$1.34M$0$0$0$0$24K
Current Income Tax Payable$0$0$0$0$0$0
Current Unearned Revenue$0$0$37K$10K$0$0
Other Current Liabilities$418K$549K$369K$68K$0$16K
Total Current Liabilities$3.94M$1.8M$1.3M$588K$216K$41K
Long-Term Liabilities
Long-Term Debt$1.06M$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$31K$0$0$0$0$0
Other Long-Term Liabilities$0$534K$0$0$0$0
Total Long-Term Liabilities$1.09M$534K$65K$173K$0$0
Other Liabilities$0$0$0$0$0$0
Total Liabilities$5.03M$2.33M$1.36M$761K$216K$41K
Stockholders' Equity
Preferred Stock$637$0$0$571$385$21
Common Stock$8$44$2K$957$952$848
Retained Earnings-$21.02M-$13.27M-$7.02M-$2.72M-$922K-$137K
Comprehensive Income & Other-$2K-$337$202$111$202-$1K
Other Stockholders' Equity$28.85M$19.93M$10.85M$3.85M$1.37M$113K
Total Equity$7.84M$6.66M$3.83M$1.13M$451K-$24K
Minority Interest$0$0$0$0$0$0
Total Liabilities and Equity$12.87M$8.99M$5.19M$1.89M$666K$17K
Supplementary Data
Total Debt$2.64M$0$210K$283K$0$24K
Net Debt-$2.76M-$3.98M-$3.12M-$872K-$412K$11K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Operating Activities
Net Income-$7.75M-$6.25M-$4.3M-$1.8M-$785K-$223K
Depreciation & Amortization$111K$13K$12K$7K$3K$222K
Deferred Income Tax$31K$0$0$0$0$0
Stock-Based Compensation-$19K$97K$488K$172K$142K$0
Changes in Working Capital:
  Accounts Receivable-$101K-$13K-$23K-$12K-$1K-$605
  Inventory$148K-$403K-$266K-$69K-$161K$0
  Accounts Payable$958K$207K$467K$65K$192K$0
  Other Working Capital-$417K$460K-$1M$28K-$52K$7K
Total Working Capital Change$588K$252K-$823K$12K-$22K$7K
Other Non-Cash Items$1.1M$397K$69K$24K$600-$223K
Net Cash from Operating-$5.93M-$5.49M-$4.56M-$1.59M-$661K-$217K
Investing Activities
Capital Expenditures-$448K-$9K-$11K-$36K-$32K$0
Acquisitions-$2.16M$0$0$0$0$0
Purchases of Investments-$1.79M-$139K$0$0$0$0
Sales of Investments$1.76M$0$0$0$0$0
Other Investing Activities-$127K-$462K$0$4K$0$0
Net Cash from Investing-$2.77M-$611K-$11K-$32K-$32K$0
Financing Activities
Debt Repaid-$236K----
Common Stock Issuance$6.13M$6.99M$7.46M$25K$0$115K
Common Stock Repurchases-$179$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0
Other Financing Activities$3.99M$0-$725K$0$0$123K
Net Cash from Financing$10.12M$6.76M$6.74M$2.36M$1.09M$238K
Forex Effect$177-$2K$1K-$1K$1K-$2K
Net Change in Cash$1.42M$658K$2.17M$743K$399K$20K
Supplementary Data
Operating Cash Flow-$5.93M-$5.49M-$4.56M-$1.59M-$661K-$217K
Capital Expenditure-$448K-$9K-$11K-$36K-$32K$0
Free Cash Flow-$6.38M-$5.49M-$4.57M-$1.62M-$693K-$217K
Cash at Beginning$3.98M$3.33M$1.15M$412K$13K$0
Cash at End$5.4M$3.98M$3.33M$1.15M$412K$20K